Andreas Holm Mattsson
CSO and co-founder
Andreas is an experienced bioinformatician from the Technical University of Denmark. Prior to working at Evaxion, Andreas spent six years at Novo Nordisk developing in silico platforms.
Since the founding of Evaxion in 2008, Andreas has worked on developing Evaxion’s in silico platforms including EDEN and PIONER and numerous other in silico tools enabling vaccine discovery in the area of infectious diseases and immune oncology.